Last reviewed: June 26, 2026
Last updated: June 26, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Wegovy produces measurable weight reduction through GLP-1 receptor activation, which signals satiety and reduces hunger. Most patients experience an average monthly weight loss between 4 and 8 pounds when combined with lifestyle changes, though individual results vary based on genetics, metabolism, and adherence. PlexusDx offers compounded semaglutide injections from licensed 503A pharmacies that deliver the same active ingredient at a fraction of the cost.
How Much Weight Do Patients Lose Monthly on Wegovy?
Clinical trials of semaglutide (the active ingredient in Wegovy) showed participants lost approximately 4 to 8 pounds per month during the initial 16 weeks of treatment. Patients who continued therapy for the full year achieved an average total weight loss of 15% of their starting body weight. The pace of weight loss typically accelerates during weeks 1 through 12 as the body adjusts to the medication and hunger signals decrease.
Monthly weight loss is not linear. Many patients experience rapid initial losses in the first four weeks, followed by a plateau period around weeks 8 to 12, then resumed progress as the dose increases. Starting with lower doses and titrating upward allows the body to adapt while minimizing gastrointestinal side effects that might otherwise interrupt treatment continuity.
Factors That Influence Monthly Weight Loss Results
Individual weight loss varies based on baseline metabolic rate, adherence to medication timing, diet quality, physical activity level, and sleep patterns. Genetic variants in pathways controlling appetite (such as GLP1R and GIPR gene variants) determine how efficiently a person's body responds to semaglutide therapy. Patients with certain genetic predispositions may lose weight faster or require different doses than average populations.
PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after first month) to identify your unique peptide-pathway profile across 49 peptides and 14 metabolic pathways. This test analyzes key variants including GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609, allowing your healthcare provider to personalize your treatment plan for optimal monthly outcomes.
Compounded Semaglutide vs. Brand-Name Wegovy Results
Compounded semaglutide injections from licensed 503A pharmacies contain the identical active pharmaceutical ingredient as Wegovy, produced to the same purity and potency standards. Clinical efficacy is equivalent when doses are matched and patients follow the same titration schedule. The primary difference is cost: PlexusDx compounded semaglutide starts at $149 per month, while Wegovy costs significantly more through traditional insurance or cash-pay routes.
Monthly weight loss on PlexusDx compounded semaglutide follows the same trajectory as Wegovy because the pharmacological mechanism is identical. Patients can expect 4 to 8 pounds of loss per month during the active titration phase, with cumulative results approaching 15% body weight reduction over 12 months. Your dose may increase during treatment to maintain efficacy, but PlexusDx pricing remains flat—your dose may go up, your price won't.
Maximizing Monthly Weight Loss: Lifestyle and Medication Synergy
Weight loss on semaglutide accelerates when combined with consistent moderate exercise, protein-rich nutrition, adequate hydration, and seven to nine hours of nightly sleep. GLP-1 medications reduce appetite but do not eliminate the need for calorie awareness; patients who undereat may plateau or experience muscle loss alongside fat loss. Pairing medication with behavioral changes typically produces 2 to 3 additional pounds of monthly loss compared to medication alone.
PlexusDx patients receive access to personalized treatment plans based on their genetic profile and health history. Starting treatment at $149 per month with a licensed 503A compounded semaglutide injection, patients can titrate their dose over 4 to 8 weeks while implementing dietary and exercise modifications. All 50 states are served, no insurance is required, and treatment is HSA/FSA eligible, removing financial barriers to consistent adherence.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the typical amount of weight loss per month on semaglutide?
Most patients lose between 4 and 8 pounds per month during the first 12 to 16 weeks of semaglutide therapy. Weight loss typically slows after three months as the body adapts, then resumes when doses increase further during titration.
Is weight loss the same on compounded semaglutide as on Wegovy?
Yes. Compounded semaglutide from licensed 503A pharmacies contains the same active ingredient as Wegovy and produces identical clinical results when dosed equivalently. PlexusDx compounded semaglutide starts at $149 per month with equivalent efficacy.
Can genetic testing help predict my monthly weight loss?
PlexusDx Precision Peptide Genetic Test identifies your unique variants in GLP1R, GIPR, FTO, and MC4R genes that influence appetite and metabolism. These insights help personalize your semaglutide dose and treatment protocol for potentially faster and more predictable monthly results.
Why do some patients lose weight faster than others on semaglutide?
Individual differences in genetic predisposition, baseline metabolic rate, adherence to lifestyle changes, and GLP-1 receptor sensitivity determine the pace of weight loss. Genetic variants in appetite-control pathways can accelerate or decelerate monthly loss by 1 to 2 pounds compared to population averages.
Does PlexusDx pricing increase if my semaglutide dose goes higher?
No. PlexusDx compounded semaglutide injections remain at $149 per month regardless of dose level during titration. Your dose may increase from 0.25 mg to 2.4 mg over months, but your monthly cost stays flat across all tiers.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Where on My Stomach Should I Inject Zepbound? A Comprehensive Guide
A Comprehensive Guide on How to Open Your Wegovy Pen